Key result
Expression of a chimeric tropomyosin containing the internal β-TM domain (amino acids 175-190) in transgenic mice significantly increased myofilament Ca2+ sensitivity and decreased rates of cardiac contraction.
A specific internal domain within beta-tropomyosin (amino acids 175-190) increases myofilament Ca2+ sensitivity, providing insight into the mechanisms of familial hypertrophic cardiomyopathy mutations.
Answers are grounded in this paper and cite their sources.
Informs β-TM domain function in myofilament regulation; leaves open translation to human HCM.
Tropomyosin (TM) is involved in Ca(2+)-mediated muscle contraction and relaxation in the heart. Striated muscle alpha-TM is the major isoform expressed in the heart. The expression of striated muscle beta-TM in the murine myocardium results in a decreased rate of relaxation and increased myofilament Ca(2+) sensitivity. Replacing the carboxyl terminus (amino acids 258-284) of alpha-TM with beta-TM (a troponin T-binding region) results in decreased rates of contraction and relaxation in the heart and decreased myofilament Ca(2+) sensitivity. We hypothesized that the putative internal troponin T-binding domain (amino acids 175-190) of beta-TM may be responsible for the increased myofilament Ca(2+) sensitivity observed when the entire beta-TM is expressed in the heart. To test this hypothesis, we generated transgenic mice that expressed chimeric TM containing beta-TM amino acids 175-190 in the backbone of alpha-TM (amino acids 1-174 and 191-284). These mice expressed 16-57% chimeric TM and did not develop cardiac hypertrophy or any other morphological changes. Physiological analysis showed that these hearts exhibited decreased rates of contraction and relaxation and a positive response to isoproterenol. Skinned fiber bundle analyses showed a significant increase in myofilament Ca(2+) sensitivity. Biophysical experiments demonstrated that the exchanged amino acids did not influence the flexibility of the TM. This is the first study to demonstrate that a specific domain within TM can increase the Ca(2+) sensitivity of the thin filament and affect sarcomeric performance. Furthermore, these results enhance the understanding of why TM mutations associated with familial hypertrophic cardiomyopathy demonstrate increased myofilament sensitivity to Ca(2+).
No takes yet. Share an insight, caveat, or question.
Jagatheesan et al. (2009) studied Myofilament Ca2+ sensitivity and cardiac contractile function. Chimeric α/β-TM-3 expression vs. Nontransgenic (NTG) littermates was evaluated on Myofilament Ca2+ sensitivity (pCa50 at 1.9 μm sarcomere length) (p=<0.001). Expression of a chimeric tropomyosin containing the internal β-TM domain (amino acids 175-190) in transgenic mice significantly increased myofilament Ca2+ sensitivity and decreased rates of cardiac contraction.
Synapse has enriched 10 related papers. Consider them for comparative context: